**Chapter 6**

*Advanced Concepts in Endocarditis - 2021*

Seville, Spain. 2018. p. 30

[125] Schneider T, Moos V,

al estudio de endocarditis infecciosa en tejido valvular? In: Programme of the VIII Congreso de la Sociedad Española de Infecciones cardiovasculares (SEICAV); 16-17 November 2018;

to trimethoprim and sulphonamides in vitro. International Journal of Antimicrobial Agents. 2014;**43**:388-390

[132] Fenollar F, Rolain JM, Alric L, Papo T, Chauveheid MP, van de Beek D, et al. Resistance to trimethoprim/ sulfamethoxazole and Tropheryma whipplei. International Journal of Antimicrobial Agents. 2009;**34**:255-259. DOI: 10.1016/j.ijantimicag.2009.02.014

[133] García-Álvarez L, Sanz MM, Marín M, Fariñas MC, Montejo M, Goikoetxea J, et al. Antimicrobial management of Tropheryma whipplei endocarditis: the Spanish Collaboration on Endocarditis (GAMES) experience.

The Journal of Antimicrobial

10.1093/jac/dkz059

Chemotherapy. 2019;**74**:1713-1717. DOI:

[134] Lagier JC, Raoult D. Whipple's disease and Tropheryma whipplei infections: When to suspect them and how to diagnose and treat them. Current Opinion in Infectious Diseases.

2018;**31**:463-470. DOI: 10.1097/ QCO.0000000000000489

Loddenkemper C, Marth T, Fenollar F, Raoult D. Whipple's disease: New aspects of pathogenesis and treatment. The Lancet Infectious Diseases. 2008;**8**:179-190. DOI: 10.1016/ S1473-3099(08)70042-2

[126] Feurle GE, Moos V, Bläker H, Loddenkemper C, Moter A, Stroux A, et al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple's disease. The Journal of Infection. 2013;**66**:263-270. DOI:

[127] Fenollar F, Puéchal X, Raoult D. Whipple's disease. The New England Journal of Medicine. 2007;**356**:55-66.

[128] Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/

sulfamethoxazole in classic Whipple's disease. The Journal of Antimicrobial Chemotherapy. 2010;**65**:2005-2012.

[129] Raoult D, Ogata H, Audic S, Robert C, Suhre K, Drancourt M, et al. Tropheryma whipplei twist: A human pathogenic actinobacteria with a reduced genome. Genome Research. 2003;**13**:1800-1809. DOI: 10.1101/

[130] Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease. Gastroenterology. 2010;**138**:478-486. DOI: 10.1053/j.gastro.2009.10.041

[131] Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance

10.1016/j.jinf.2012.12.004

DOI: 10.1056/NEJMra062477

DOI: 10.1093/jac/dkq263

**88**

gr.1474603
